EYSUVIS can help relieve your symptoms by targeting a key cause of Dry Eye, inflammation.

EYSUVIS WORKS QUICKLY TO GIVE
YOU
FAST RELIEF* FOR YOUR
DRY EYE FLARES.

Learn more about how EYSUVIS can treat
YOUR DRY EYE AND DRY EYE FLARES

Activate your
co-pay card
from the
Activate your EYSUVIS Co-pay Card from the EYSUVIS I SAVE Patient Access Program
EYSUVIS campaign character holding EYSUVIS bottle EYSUVIS campaign character holding EYSUVIS bottle
  • *In a clinical trial program with 2871 patients with Dry Eye, patients taking EYSUVIS showed significant reduction in the symptoms of Dry Eye (ocular discomfort) as early as Day 4 after starting treatment (versus placebo). Symptoms continued to improve up to the end of the treatment period (Day 15). Patients taking EYSUVIS also showed significant reduction in signs of Dry Eye (eye redness) at Day 15 versus placebo.

Important Safety
Information

EYSUVIS should not be used if you have a viral infection in your eye. Talk to your doctor before using EYSUVIS if you think you may have a viral, bacterial, or fungal eye infection.

Your doctor should examine your eyes before prescribing EYSUVIS, to check for increased eye pressure or damage to the surface of the eye. Consult your doctor if pain, redness, itching, or inflammation develops or gets worse.

Wash your hands well before each use. Do not allow the dropper tip to touch any surface, as this may contaminate the suspension. Shake the bottle for two to three seconds before using. If a dose is missed, take the missed dose when remembered.

Remove contact lenses before using EYSUVIS; they may be reinserted 15 minutes later.

The most common adverse drug reaction following the use of EYSUVIS for two weeks was instillation site pain, which was reported in 5% of patients.

Indication

EYSUVIS is a corticosteroid indicated for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease.

Please see full Prescribing Information.